Intimate Partner Violence (IPV) Screening and Referral Outcomes among Transgender Patients in a Primary Care Setting

Transgender patients are at elevated risk of intimate partner violence (IPV), but national guidelines do not recommend routine screening for this population. This paper explores the feasibility and effectiveness of routine IPV screening of transgender patients in a primary care setting by describing...

Full description

Saved in:  
Bibliographic Details
Main Author: Das, Kirsten J. H. (Author)
Contributors: Peitzmeier, Sarah ; Berrahou, Iman K. ; Potter, Jennifer
Format: Electronic Article
Language:English
Published: 2022
In: Journal of interpersonal violence
Year: 2022, Volume: 37, Issue: 13/14, Pages: NP11720-NP11742
Online Access: Volltext (lizenzpflichtig)
Journals Online & Print:
Drawer...
Check availability: HBZ Gateway
Keywords:

MARC

LEADER 00000naa a22000002c 4500
001 1884211453
003 DE-627
005 20240325124828.0
007 cr uuu---uuuuu
008 240325s2022 xx |||||o 00| ||eng c
024 7 |a 10.1177/0886260521997460  |2 doi 
035 |a (DE-627)1884211453 
035 |a (DE-599)KXP1884211453 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 2,1  |2 ssgn 
100 1 |a Das, Kirsten J. H.  |e VerfasserIn  |4 aut 
245 1 0 |a Intimate Partner Violence (IPV) Screening and Referral Outcomes among Transgender Patients in a Primary Care Setting 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Transgender patients are at elevated risk of intimate partner violence (IPV), but national guidelines do not recommend routine screening for this population. This paper explores the feasibility and effectiveness of routine IPV screening of transgender patients in a primary care setting by describing an existing screening program and identifying factors associated with referral and engagement in IPV-related care for transgender patients. An IPV ?referral cascade? was created for 1,947 transgender primary care patients at an urban community health center who were screened for IPV between January 1, 2014 to May 31, 2016: (a) Of those screening positive, how many were referred? (b) Of those referred, how many engaged in IPV-specific care within 3 months? Logistic regression identified demographic correlates of referral and engagement. Of the 1,947 transgender patients screened for IPV, 227 screened positive. 110/227 (48.5%) were referred to either internal or external IPV-related services. Of those referred to on-site services, 65/103 (63.1%) had an IPV-related appointment within 3 months of a positive screen. IPV referral was associated with being assigned male at birth (AMAB) versus assigned female at birth (AFAB) (AOR = 2.69, 95% CI 1.52, 4.75) and with nonbinary, rather than binary, gender identity (AOR = 2.07, 95%CI 1.09, 3.73). Engagement in IPV-related services was not associated with any measured demographic characteristics. Similar to published rates for cisgender women, half of transgender patients with positive IPV screens received referrals and two-thirds of those referred engaged in IPV-specific care. These findings support routine IPV screening and referral for transgender patients in primary care settings. Provider training should focus on how to ensure referrals are made for all transgender patients who screen positive for IPV, regardless of gender identity, to ensure the benefits of screening accrue equally for all patients. 
650 4 |a behavioral health 
650 4 |a community health centers 
650 4 |a integrated primary care 
650 4 |a Intimate Partner Violence 
650 4 |a transgender health 
700 1 |a Peitzmeier, Sarah  |e VerfasserIn  |4 aut 
700 1 |a Berrahou, Iman K.  |e VerfasserIn  |4 aut 
700 1 |a Potter, Jennifer  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of interpersonal violence  |d London [u.a.] : Sage, 1986  |g 37(2022), 13/14, Seite NP11720-NP11742  |h Online-Ressource  |w (DE-627)324614721  |w (DE-600)2028900-5  |w (DE-576)276556305  |x 1552-6518  |7 nnas 
773 1 8 |g volume:37  |g year:2022  |g number:13/14  |g pages:NP11720-NP11742 
856 4 0 |u https://doi.org/10.1177/0886260521997460  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4503486187 
LOK |0 003 DE-627 
LOK |0 004 1884211453 
LOK |0 005 20240325124828 
LOK |0 008 240325||||||||||||||||ger||||||| 
LOK |0 040   |a DE-2619  |c DE-627  |d DE-2619 
LOK |0 092   |o n 
LOK |0 852   |a DE-2619 
LOK |0 852 1  |9 00 
LOK |0 866   |x zotak: Nacherfasst, da in zota-Errors 
LOK |0 935   |a krzo 
ORI |a SA-MARC-krimdoka001.raw